Hakutulokset - Syversen, Silje W

A high serum level of eotaxin (CCL 11) is associated with less radiographic progression in early rheumatoid arthritis patients Tekijä Syversen, Silje W, Goll, Guro L, Haavardsholm, Espen A, Bøyesen, Pernille, Lea, Tor, Kvien, Tore K

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Antibodies to cyclic citrullinated protein and erythrocyte sedimentation rate predict hand bone loss in patients with rheumatoid arthritis of short duration: a longitudinal study Tekijä Bøyesen, Pernille, Hoff, Mari, Ødegård, Sigrid, Haugeberg, Glenn, Syversen, Silje W, Gaarder, Per I, Okkenhaug, Cecilie, Kvien, Tore K

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Rheumatoid factor and falsely elevated results in commercial immunoassays: data from an early arthritis cohort Tekijä Gehin, Johanna E., Klaasen, Rolf A., Norli, Ellen S., Warren, David J., Syversen, Silje W., Goll, Guro L., Bjøro, Trine, Kvien, Tore K., Mjaavatten, Maria D., Bolstad, Nils

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Immune response and safety in standard and third dose SARS-CoV-2 vaccination in patients with autoimmune hepatitis on immunosupressive therapy, a prospective cohort study Tekijä Jorgensen, Kristin, Chopra, Adity, Sexton, Joseph, Tveter, Anne T, Hov, Johannes R., Jyssum, Ingrid, Nissen-Meyer, Lise Sofie H., Vaage, John T, Syversen, Silje W, Goll, Guro L, Lund-Johansen, Fridtjof, Jahnsen, Jørgen

Hae kokoteksti Hae kokoteksti

Therapeutic drug monitoring of infliximab compared to standard clinical treatment with infliximab: study protocol for a randomised, controlled, open, parallel-group, phase IV study... Tekijä Syversen, Silje W, Goll, Guro L, Jørgensen, Kristin K, Olsen, Inge C, Sandanger, Øystein, Gehin, Johanna E, Warren, David J, Sexton, Joseph, Mørk, Cato, Jahnsen, Jørgen, Kvien, Tore K, Bolstad, Nils, Haavardsholm, Espen A

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Immunogenicity and Safety of Standard and Third‐Dose SARS–CoV‐2 Vaccination in Patients Receiving Immunosuppressive Therapy Tekijä Syversen, Silje W., Jyssum, Ingrid, Tveter, Anne T., Tran, Trung T., Sexton, Joseph, Provan, Sella A., Mjaaland, Siri, Warren, David J., Kvien, Tore K., Grødeland, Gunnveig, Nissen‐Meyer, Lise S. H., Ricanek, Petr, Chopra, Adity, Andersson, Ane M., Kro, Grete B., Jahnsen, Jørgen, Munthe, Ludvig A., Haavardsholm, Espen A., Vaage, John T., Lund‐Johansen, Fridtjof, Jørgensen, Kristin K., Goll, Guro L.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Sa1052: IMMUNOGENICITY AND SAFETY OF STANDARD AND THIRD DOSE SARS-COV-2 VACCINATION IN PATIENTS WITH IMMUNE-MEDIATED INFLAMMATORY DISEASES; A PROSPECTIVE COHORT STUDY Tekijä Joergensen, Kristin K., Syversen, Silje W, Jyssum, ingrid, Tveter, Anne Therese, Tran, Trung T., Sexton, Joe, Provan, Sella A., Mjaaland, Siri, Warren, David J., Kvien, Tore K., Gr⊘deland, Gunnveig, Nissen-Meyer, Lise Sofie H., Ricanek, Petr, Chopra, Adity, Anderson, Ane M., Kro, Grete B., Munthe, Ludvig A., Haavardsholm, Espen A., Vaage, John T.T., Lund-Johansen, Fridtjof, Jahnsen, Jorgen, Goll, Guro L.

Hae kokoteksti Hae kokoteksti